Investigational Site Number : 2500002

Bordeaux 33076

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer

Studies at this site

• Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer — Stopped early
• Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies — Stopped early